JournalQ2· SCImago 2025
BMC Cancer
ISSN 1471-2407
- Q2Quartile
- 1.00SJR
- 180h-index
- 15papers summarised
About this journal
BMC Cancer is a Q2 journal by SCImago Journal Rank (2025 data), with an SJR of 1.00 and an h-index of 180. Pofolia holds AI summaries of 15 paper(s) from this journal; the most cited is “Cognitive burden and supportive care needs in dyads of older patients with hematologic…” (0 citations).
The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal? · What is the h-index?
Papers we summarise from this journal
- Cognitive burden and supportive care needs in dyads of older patients with hematologic malignancies and their primary caregivers: a cross-sectional survey2026 · 0 citations
- Prognosis and associations between reproductive factors and molecular subtypes in Chinese women with pregnancy-associated and non-pregnancy-associated breast cancer: a retrospective cohort study2026 · 0 citations
- Neoadjuvant immunochemotherapy and pathological response in locally advanced cervical cancer: a real-world bicenter cohort study2026 · 0 citations
- Predicting pathologic complete response in locally advanced breast cancer post-neoadjuvant chemotherapy: a novel nomogram integrating immune-inflammation indices and clinicopathological data2026 · 0 citations
- Decoupling T cell cytotoxicity: a CCL21+ICAM1-based synthetic immune niche enhances tumor elimination by accelerating lytic hit delivery2026 · 0 citations
- Disparities in late-stage cancer diagnosis across a multi-site academic health system2026 · 0 citations
- Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain Management (ASCENT): Protocol for a Randomized Clinical Trial2026 · 0 citations
- Efficacy and safety of radiofrequency ablation for high-risk locations of T1aN0M0 papillary thyroid carcinoma: a retrospective cohort study2026 · 0 citations
- Sacituzumab govitecan in heavily pretreated metastatic triple-negative breast cancer: a secondary analysis of the CEBCC-102 real-world cohort2026 · 0 citations
- Frequency of positive margins and predictors in breast-conserving surgery in developing countries2026 · 0 citations
- ADAM17 pathway promotes canine mammary tumor cell migration2026 · 0 citations
- In-hospital mortality among intracranial tumor admissions at a tertiary hospital in Luanda, Angola: a retrospective cohort study2026 · 0 citations
- Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial2026 · 0 citations
- Induction failure and early death in paediatric acute myeloid leukaemia in Uganda: a developing country experience2026 · 0 citations
- Preventability of adverse drug reactions to anticancer drugs: insights from the database of the Regional Drug Information and Pharmacovigilance Center2026 · 0 citations
Journals in the same field
| Journal | Quartile | SJR | Summaries |
|---|---|---|---|
| Ca-A Cancer Journal for Clinicians | Q1 | 104.00 | 1 |
| Nature Cancer | Q1 | 12.00 | 1 |
| Nature Communications | Q1 | 4.00 | 1 |
| Science Advances | Q1 | 4.00 | 1 |
| EMBO Journal | Q1 | 4.00 | 1 |
| Journal of Experimental and Clinical Cancer Research | Q1 | 3.00 | 2 |
| JAMA Network Open | Q1 | 3.00 | 1 |
| Advanced Science | Q1 | 3.00 | 1 |
| Cell Death and Disease | Q1 | 3.00 | 1 |
| Cell Reports | Q1 | 3.00 | 1 |
Follow these journals on Pofolia
Pick your fields and new papers from their journals land in your feed every day with AI summaries. Free.
Start free